News

As the CSA prepares to launch Matter 1.5 this fall, a 1.4.2 update is setting the stage to improve your user experience.
V2X took in $4.3 billion in revenue last year, up 9% from 2023 -- a respectable growth rate for a defense contractor, if perhaps a bit on the slow side for a small-cap defense contractor.
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Claude Opus 4.1 scores 74.5% on the SWE-bench Verified benchmark, indicating major improvements in real-world programming, bug detection, and agent-like problem solving.
WordPress vulnerability in three popular file manager plugins installed in up to 1.3 million sites enables arbitrary file deletion ...
Anthropic says Claude Opus 4.1 improves software engineering accuracy to 74.5%. That compares to 62.3% with Claude Sonnet 3.7 and 72.5% with Claude Opus 4.
A new video game company claims that the Nintendo Switch 2 has support for DLSS 3.1, far in advance of what games press assumed.
Attain-1 met its main goal, with the highest dose of orforglipron taken once every day tied to 12.4% (27.3 pounds) weight loss at 72 weeks.
Barcode scanner maker Zebra Technologies is expanding its retail-focused business with a $1.3 billion buyout of touchscreen maker Elo Touch Solutions, after upbeat second-quarter results fueled by ...
Claude Opus 4.1 introduces significant advancements in reasoning, coding, task execution, multilingual processing, and data analysis, enhancing its versatility across industries.
ChatGPT 5 vs Claude Opus 4.1: Discover which AI coding assistant delivers better code quality, usability, and performance for your needs.
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.